CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PYRAPREG-extended focuses on evaluating the effectiveness and safety of Pyronaridine-Artesunate for treating uncomplicated malaria in pregnant women in Africa. It also includes a follow-up study of children born to participants and aims to enhance research capacity through PhD training.
PYRAPREG-extended aims to complete PYRAPREG project (PACTR 202011812241529) that determines efficacy and safety of Pyronaridine-Artesunate (PA) - PYRAMAX®, a newly registered Artemisinin-Based Combination, to treat uncomplicated malaria in African pregnant women, and to provide the necessary information to include this treatment in guidelines for management of malaria during pregnancy.
The work includes a one year follow-up of children born to women included in the trial and pharmacokinetic (PK)…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Mali, Bamako
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Uppsala
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Burkina Faso, Ouagadougou
Type: Research institute
Activity type: Research Organisations
SME: No
Congo - Kinshasa, KINSHASA
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
